Vanguard Capital Management
INBS icon

Vanguard Capital Management’s Intelligent Bio Solutions INBS Stock Holding History

Vanguard Capital Management’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Hold
5,810
– – ﹤0.01% 4035
2026
Q1 		$19.4K Buy
+5,810
New +$40.1K ﹤0.01% 3985

Other funds holding INBS

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Capital Management's INBS Position: Q2 2026 in Review

Vanguard Capital Management held its Intelligent Bio Solutions (INBS) position steady in Q2 2026 at 5,810 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4035.

Vanguard Capital Management first reported a position in INBS in Q1 2026 and has held it in 2 quarters since. The position peaked at $19.4K in Q1 2026. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2026.

  • Vanguard Capital Management held 5,810 shares of Intelligent Bio Solutions worth $13.3K as of Q2 2026.
  • Vanguard Capital Management left its Intelligent Bio Solutions share count unchanged in Q2 2026.
  • Intelligent Bio Solutions made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #4035 holding.
  • Vanguard Capital Management first reported a position in Intelligent Bio Solutions in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Intelligent Bio Solutions position peaked at $19.4K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.